Syra Health Corp. Class A Common Stock
SYRA
SYRA was delisted on the 17th of April, 2025.
0 hedge funds and large institutions have $0 invested in Syra Health Corp. Class A Common Stock in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.
100% less funds holding
Funds holding: 2 → 0 (-2)
100% less capital invested
Capital invested by funds: $18.8K → $0 (-$18.8K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$16.4K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$2.43K |
SYRA Hedge Fund Activity: Q3 2025 in Review
0 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Syra Health Corp. Class A Common Stock (SYRA) for Q3 2025, worth a combined $0 — down 100% from $18.8K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of SYRA and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Jane Street, exiting entirely with an estimated $16.4K sold.
- 0 institutional investors held Syra Health Corp. Class A Common Stock (SYRA) as of Q3 2025, down from 2 in Q2 2025.
- Funds reported $0 of Syra Health Corp. Class A Common Stock stock for Q3 2025, down 100% quarter-over-quarter.
- 0 funds opened new Syra Health Corp. Class A Common Stock positions in Q3 2025 and 2 closed out, a net change of -2 holders.
- The largest Syra Health Corp. Class A Common Stock seller in Q3 2025 was Jane Street, an estimated $16.4K sold.
Based on aggregated 13F filings for Q3 2025.